Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems

TH Baryakova, BH Pogostin, R Langer… - Nature Reviews Drug …, 2023 - nature.com
Poor medication adherence is a pervasive issue with considerable health and
socioeconomic consequences. Although the underlying reasons are generally understood …

Intranasal drug delivery: opportunities and toxicologic challenges during drug development

LA Keller, O Merkel, A Popp - Drug delivery and translational research, 2022 - Springer
Over the past 10 years, the interest in intranasal drug delivery in pharmaceutical R&D has
increased. This review article summarises information on intranasal administration for local …

Alginate as a promising biopolymer in drug delivery and wound healing: A review of the state-of-the-art

MAS Abourehab, RR Rajendran, A Singh… - International Journal of …, 2022 - mdpi.com
Biopolymeric nanoparticulate systems hold favorable carrier properties for active delivery.
The enhancement in the research interest in alginate formulations in biomedical and …

Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs

M Agrawal, S Saraf, S Saraf, SG Antimisiaris… - Journal of controlled …, 2018 - Elsevier
Abstract According to the Alzheimer Association Report (2017), Alzheimer's disease (AD) is
the 6th primary cause of death in the USA, which affects nearly 5.5 million people. In the …

[HTML][HTML] Nanostructured lipid carriers for site-specific drug delivery

A Khosa, S Reddi, RN Saha - Biomedicine & Pharmacotherapy, 2018 - Elsevier
Nanostructured lipid carriers (NLC), comprises of a blend of solid and liquid lipids which
results in a partially crystallized lipid system and imparts many advantages over solid lipid …

Recent advances in the development of in situ gelling drug delivery systems for non-parenteral administration routes

B Vigani, S Rossi, G Sandri, MC Bonferoni… - Pharmaceutics, 2020 - mdpi.com
In situ gelling drug delivery systems have gained enormous attention over the last decade.
They are in a sol-state before administration, and they are capable of forming gels in …

Recent advances in intranasal liposomes for drug, gene, and vaccine delivery

VA Duong, TTL Nguyen, HJ Maeng - Pharmaceutics, 2023 - mdpi.com
Liposomes are safe, biocompatible, and biodegradable spherical nanosized vesicles
produced from cholesterol and phospholipids. Recently, liposomes have been widely …

Nasal route for vaccine and drug delivery: Features and current opportunities

YL Mato - International journal of pharmaceutics, 2019 - Elsevier
Mucosal administration, and specifically nasal route, constitutes an alternative and
promising strategy for drug and vaccine delivery. Mucosal routes have several advantages …

Current state and future directions of intranasal delivery route for central nervous system disorders: a scientometric and visualization analysis

H Wu, Y Zhou, Y Wang, L Tong, F Wang… - Frontiers in …, 2021 - frontiersin.org
Background: The management of various central nervous system (CNS) disorders has been
challenging, due to highly compact blood-brain barrier (BBB) impedes the access of most …

Design and application in delivery system of intranasal antidepressants

J Xu, J Tao, J Wang - Frontiers in Bioengineering and Biotechnology, 2020 - frontiersin.org
One of the major reasons why depressed patients fail their treatment course is the existence
of the blood-brain barrier (BBB), which prevents drugs from being delivered to the central …